4//SEC Filing
Dube Michael P 4
Accession 0000950170-25-003032
CIK 0001652130other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 5:23 PM ET
Size
14.4 KB
Accession
0000950170-25-003032
Insider Transaction Report
Form 4
Dube Michael P
VP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-01-03$12.18/sh−1,372$16,711→ 45,640 total
Footnotes (1)
- [F1]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2025, and does not represent a volitional trade by the Reporting Person.
Documents
Issuer
Intellia Therapeutics, Inc.
CIK 0001652130
Entity typeother
Related Parties
1- filerCIK 0002019493
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 5:23 PM ET
- Size
- 14.4 KB